The Strategic Policy of Enterprise Production:

standardize management, safety production, improve quality, reduce cost, ensure market, cooperate and innovate.

The Strategic Policy of Enterprise Marketing:

Culture first, academic guidance, specialized marketing, large variety strategy, multi-mode operation, breakthrough in point and all-round development.

Momentum always adheres to the enterprise development strategy of "Market network construction as basis, brand construction as core, quality construction as life, cultural construction as pillar, and scientific construction for development."; adheres to the marketing strategy of "culture first, academic guidance, specialized marketing, large variety strategy, multi-mode operation, point breakthrough, and comprehensive development"; adheres to "Safe production, standardized management, improved quality, reduced cost, guaranteed market and cooperative innovation"; taken on the company's mission of "devoting to health and inheriting virtue"; persist in the company's tenet of "providing patients with high-quality TCM medicine, effective treatment plan and healthy service". Momentum continuously tap the potential and value of TCM medicine, dedicate to the revitalization and development of the pharmaceutical industry, carry forward and inherit the TCM culture, let TCM go to the world, let Momentum become one of the strong ones of TCM, and make greater contributions to the cause of human health!  

Momentum Qixuehe Pharmaceutical Co., Ltd. always adheres to the corporate culture concept of "honest, law-abiding and enterprise", always adheres to the development concept of "being a science and technology-based TCM medicine enterprise, making high-quality TCM medicine", strives to improve the core competitiveness of the enterprise, and creates the brand and business status of the enterprise. In 2014, Momentum pharmaceutical wholly acquired Lijun Qinling National Pharmaceutical and in 2015, wholly merged and reorganized Shaanxi Qilin Pharmaceutical and won the honors of "High-tech Enterprise", "Model Enterprise of pharmaceutical industry in Shaanxi Province" for many consecutive years. In 2018 "Shaanxi province promotes high quality development of private economy" conference, Momentum awarded "100 excellent private enterprises" and "100 excellent private entrepreneurs". ”Momentum was awarded the honorable title of "excellent private enterprise of Shaanxi Province" by the CPC Shaanxi Provincial Committee and Shaanxi Provincial People's government, and won the affirmation and praise of governments and associations at all levels.  

In 2014, Momentum and the Department of Science of Oxford University Students in England carried out the research on the mechanism of Xinsuning compound. In 2015, Momentum and Oxford University established the Chinese herbal medicine laboratory, which was received by Vice Premier Liu Yandong and fully affirmed and praised.In 2016, evidence-based medicine research of Xinsuning revealed that Xinsuning was 4 percentage points higher than western medicine mexiletine. The paper topic was to be published on the authoritative international Lancet, winning honor for TCM in the field of international high-end magazines. In December 2016, Xinsuning won the Industrial Award nomination approved by the State Council in the Great Hall of the people. The award was presented by Gu Xiulian, the former Vice Chairman of the State Council. In 2017, Momentum and Oxford University jointly applied for an international patent for the research results of Xinsuning. Previous studies showed that Xinsuning capsule significantly prolonged the action potential interval of cardiac myocytes. The mechanism of action was similar to that of amiodarone, a famous western medicine, but there was no side effect as amiodarone. Due to the outstanding achievements of Xin Su Ning in the electrophysiologic study of University of Oxford, in December 2017, Oxford decided to upgrade the Chinese Herbal Medicine Laboratory to the Oxford University Research Center of Traditional Chinese Medicine. As the innovation point of The Belt and Road of Chairman Xi Jinping, in December 2018 Xinsuning was included in the 10 major Chinese medicine varieties in 13th Five-Year by the Ministry of science and technology. This is the honor of Momentum people, Xianyang people and the people of Western Shaanxi. The future research goal of Xinsuning capsule is must enter the FDA research in the United States and go to the world!

爱心奉献：

摩美得制药传承古代儒学文化“仁”的思想，大力开展“致力健康，传承美德。”我参与，我在行活动，努力回馈社会，分别向雅安、玉树、甘肃岷县、漳县等地震灾区送医、送药、送物资，关爱资助贫困学生、聋哑儿童等社会弱势群体，弘扬大善若水，大爱无疆的情怀。

中医药的传承与发展：

作为一家中医药制造企业，继承好、发展好、利用好中医药文化是我们的历史责任，摩美得制药一直致力于对中医文化的收集、整理、研究与传播，近年来通过“仁医工程”大力推广中医药适宜技术，培养了一批医德高尚、医术精湛的基层医生，并多次组织专家前往英国、美国进行学术交流，为中医药走向世界贡献自己的力量。